Dr. Reddy's Laboratories Ltd., often simply referred to as Dr. Reddy's, is a leading multinational pharmaceutical company based in Hyderabad, India. Established in 1984 by renowned scientist-entrepreneur Dr. Anji Reddy, the company is dedicated to creating innovative and high-quality medicines and therapies to improve patients’ lives worldwide. Listed on the New York Stock Exchange as RDY, the company holds a significant position in the global healthcare industry.
Dr. Reddy’s Laboratories Ltd. (RDY) primary mission is to provide affordable and innovative medicines for healthier lives. Over the years, it has expanded its reach beyond India, establishing its presence in major international markets such as the United States, Russia, and the European region. The company's product portfolio is diverse, encompassing active pharmaceutical ingredients (APIs), generic medications, over-the-counter (OTC) products, and bio-similar drugs, among others.
The company has over 190 medications, 60 APIs for drug manufacture, diagnostic kits, critical care, and biotechnology products. In its constant pursuit of innovation, Dr. Reddy’s has more than 20 key brands addressing a variety of therapeutic areas such as gastroenterology, oncology, pain management, cardiovascular, dermatology, pediatrics, gynecology, diabetes, and more.
Dr. Reddy’s Laboratories Ltd. (RDY) has a rich history defined by its commitment to scientific research, with a paradigm of ‘Good Health Can't Wait.’ Its innovation-oriented strategy is reflected in its Research and Development (R&D) centers in India, the United States, and the United Kingdom, which are pivotal in its efforts to develop a robust pipeline of innovative and first-to-market products. The company has made and continues to make considerable investments in R&D, which serves as a cornerstone of their long-term growth strategy.
Furthermore, the company believes in the corporate philosophy of 'Giving back to society.' Consequently, they launched the Dr. Reddy's Foundation in 1996 to enable sustainable societal impact through initiatives addressing Education & Livelihood, Health, and Community Development.
In the corporate and financial world, Dr. Reddy's Laboratories Ltd. (RDY) adheres to the highest standards of corporate governance and ethical business practices. It ensures consistent value creation for its stakeholders, and its commitment to transparency and accountability has been widely recognized, earning the trust of its investors globally.
Despite being a giant in the pharmaceutical industry, Dr. Reddy's continues to hold its founder's ideals close to heart – that of promoting healthier lives through innovative and accessible medicines. This dedication has driven the company to new heights and will undoubtedly continue to guide its future trajectory.